Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence, fetal echocardiography, and congenital heart disease
51
Zitationen
5
Autoren
2021
Jahr
Abstract
Abstract There has been a recent explosion in the use of artificial intelligence (AI), which is now part of our everyday lives. Uptake in medicine has been more limited, although in several fields there have been encouraging results showing excellent performance when AI is used to assist in a well‐defined medical task. Most of this work has been performed using retrospective data, and there have been few clinical trials published using prospective data. This review focuses on the potential uses of AI in the field of fetal cardiology. Ultrasound of the fetal heart is highly specific and sensitive in experienced hands, but despite this there is significant room for improvement in the rates of prenatal diagnosis of congenital heart disease in most countries. AI may be one way of improving this. Other potential applications in fetal cardiology include the provision of more accurate prognoses for individuals, and automatic quantification of various metrics including cardiac function. However, there are also ethical and governance concerns. These will need to be overcome before AI can be widely accepted in mainstream use. It is likely that a familiarity of the uses, and pitfalls, of AI will soon be mandatory for many healthcare professionals working in fetal cardiology.
Ähnliche Arbeiten
Heart Disease and Stroke Statistics—2012 Update
2011 · 7.220 Zit.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2015 · 6.912 Zit.
The incidence of congenital heart disease
2002 · 6.008 Zit.
Burden of valvular heart diseases: a population-based study
2006 · 4.743 Zit.
Updated Clinical Classification of Pulmonary Hypertension
2013 · 4.179 Zit.